创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

column
Progress of Research on Precision Treatment of Glioma
HU Huimin, JIANG Tao
2021, 45(12): 884-893.
Abstract PDF
Progress of Research on Epigenetic Therapy of Glioma
ZHOU Junhu, KANG Chunsheng
2021, 45(12): 894-904.
Abstract PDF
Advances in Nanomedicines for Brain Tumor Treatments
ZHENG Yadan, KANG Ziyao, WANG Chun, LIU Yang
2021, 45(12): 905-918.
Abstract PDF
The Role of Ubiquitin-Proteasome System and Autophagy-Lysosome Pathway in Glioblastoma and their Research Progress in Drug Development
CAO Weiwei, LI Weiping, CHEN Fanfan, HUANG Guodong, CHEN Lei, MENG Xiangbao, LI Zongyang
2021, 45(12): 919-926.
Abstract PDF
Goals and Consensus of Basic and Translational Research on Glioma during China’s 14th Five-Year Plan (2021—2025)
CUI Xiaoteng, FANG Chuan, LIU Boyang, YE Minhua, ZENG Liang, WAN Feng, XIE Qi, WANG Qianghu, WANG Xiuxing, TAN Yanli, ZHOU Xiuping, WU Xudong, LI Xuejun, GUO Hongbo, YOU Yongping, KANG Chunsheng
2021, 45(12): 927-932.
Abstract PDF
Research Progress of KRAS Mutation and Tumor Metabolic Reprogramming
LI Youyun, LIU Xiaoquan
2021, 45(12): 933-940.
Abstract PDF
The Role of Long Non-coding RNAs in the Development of Renal Cancer and Prospect of Clinical Application
XU Xindi, LI Mengwei, JIN Xinrong, HU Kexin, XU Hanmei
2021, 45(12): 941-947.
Abstract PDF
Outlook for 2022: A New Benchmark in the Biopharmaceutical Industry with Equal Emphasis on Clinical Value and Innovation Quality
KONG Linghui, SHAO Liming
2021, 45(12): 948-952.
Abstract PDF
A Report of New Drugs Research and Development in 2020 (IV)
Graul A I, Sorbera L A
2021, 45(12): 953-962.
Abstract PDF